Do hepatic oxidative stress and inflammatory signaling worsen insulin resistance and drive progression from fatty liver to steatohepatitis?

The progression of metabolic liver disease is characterized by a "multiple parallel-hit" process where metabolic dysfunction, oxidative damage, and immune activation converge. In older adults, these processes are often amplified by age-related changes in mitochondrial efficiency and antioxidant capacity.

Mechanisms of hepatic insulin resistance

Evidence confirms that hepatic oxidative stress is a primary initiator of insulin resistance.

• Kinase Activation: Excess reactive oxygen species (ROS) activate stress-activated protein kinases, most notably c-Jun N-terminal kinase (JNK) and p38MAPK. These kinases catalyze the serine phosphorylation of insulin receptor substrate-1 (IRS-1), which directly blocks downstream PI3K/Akt signaling essential for glucose regulation.
• Inflammatory Cascades: Simultaneously, the IKK-β/NF-κB pathway triggers the release of pro-inflammatory cytokines such as TNF-α and IL-6. These cytokines create a feed-forward loop, further impairing insulin signaling and promoting systemic metabolic dysfunction.
• Clinical Impact: In clinical trials involving older adults, targeting these pathways has shown significant results. For instance, supplementing with glutathione precursors (GlyNAC) to reduce oxidative stress has been shown to improve insulin sensitivity, lowering HOMA-IR scores by approximately 68%.

Progression to inflammatory liver disease

The transition from simple steatosis (fatty liver) to steatohepatitis (NASH/MASH) is driven by the escalation of these cellular stressors.

• Hepatocyte Injury: ROS-induced lipid peroxidation generates toxic byproducts like malondialdehyde (MDA), which cause direct damage to hepatocyte membranes.
• Immune Recruitment: These damage signals activate Kupffer cells (liver-resident macrophages), shifting them toward a pro-inflammatory phenotype. This recruitment leads to the hallmark features of advanced disease: hepatocyte ballooning, inflammatory infiltration, and the initiation of fibrotic tissue deposition.

Bottom line

Oxidative stress and inflammation are the primary drivers of both insulin resistance and the transition from simple fatty liver to more severe steatohepatitis. Managing these factors is critical for preventing disease progression and maintaining metabolic health, especially in older populations where antioxidant defenses may be naturally reduced.